When to Seek an EMI Valuation Before Granting Options

Enterprise Management Incentive options are the most generous tax-advantaged share scheme available to UK private companies, but the reliefs depend on a small number of procedural disciplines being followed precisely. The most important of those disciplines is the order in which the valuation, the HMRC agreement and the actual grant of the options happen.

Get the order right and the process is short, predictable and protective. Get it wrong, typically by granting options first and 'fixing the paperwork later', and you put both the company and the option-holders into a position where the tax outcomes they were promised are no longer guaranteed. This article sets out the right timing, the common mistakes, and the practical sequence that works.

The right sequence

An EMI valuation should be commissioned, agreed with HMRC and formally confirmed in writing before any options are granted. The HMRC agreement provides 90 days of price certainty. Long enough to issue board minutes, finalise option agreements, brief and sign up the option-holders, and file the EMI notification within the statutory window. That is the only sequence that gives all parties the protection the scheme is designed to deliver.

In practical terms the flow is: commission the valuation as soon as the option pool is conceptually agreed by the board; provide the adviser with the accounts, cap table, articles and forecast; receive the draft report; submit VAL231 to HMRC with the report attached; receive SAV agreement (usually within two to four weeks); grant the options inside the 90-day window; and notify HMRC of the grant within the statutory deadline. The whole process is six to eight weeks end to end if information is provided promptly.

Why timing matters

The 90-day window exists because share values move. A valuation agreed in January should not be relied on for a grant in June. The company has traded, possibly raised, possibly won or lost a material contract, and the market value at the date of grant is genuinely different. HMRC's certainty is bounded; reusing an expired valuation removes the protection it was designed to provide.

If options are granted outside the 90-day window with the company relying on the older valuation, the position is not catastrophic. The EMI grant is still valid, but the price-certainty protection is gone. If HMRC later challenges the exercise price as below market value, the discount becomes a taxable benefit on exercise, taxed at marginal rates plus NIC. The option-holder loses the clean CGT treatment on the entire spread; the company picks up the employer NIC.

The 'grant first, value later' trap

The most damaging mistake is the board agreeing to grant options 'subject to valuation' and then treating the valuation as a tidy-up exercise. The option agreement records an exercise price (often a placeholder figure), the option-holder is told they have EMI options, and weeks or months later the valuation comes in at a different number. Now the company either has to re-paper the grants at the new price (with disclosure and accounting implications), or accept the original price and lose the price-certainty protection.

The fix is procedural rather than expensive: agree in the board minute that the grant takes effect on the date the option agreement is signed by both parties, after the valuation has been agreed and at the agreed exercise price. Anything earlier is a promise of options, not a grant. Promises are fine; documented grants at an unvalidated price are not.

Material change as a trigger

Even within the 90-day window, a material change in the company can reset the clock. A new funding round, a major customer win, an acquisition, the loss of a key contract, or a substantial change in trading all change the market value per share. If something materially changes between agreement and grant, a refreshed valuation is the right answer.

Material change is a question of substance. Routine trading volatility within the range used to prepare the original valuation does not require a refresh. A signed term sheet for a priced funding round at a higher per-share value does. So does the loss of a customer that was 30% of revenue. The board, with input from the adviser, should make that judgement on the day, and document it.

Aligning EMI grants with other corporate events

EMI grants do not happen in isolation. They are usually triggered by a hire, a promotion, a funding round, a refresh of the option pool, or a strategic milestone. Each of those events affects the valuation work. A new hire just before a planned funding round, for example, is best granted options at the pre-money valuation rather than waiting until the round completes and the per-share value re-rates.

Aligning the valuation, the grant and the corporate event takes a little planning but pays off in both tax efficiency and motivational power. Options granted at a fair, defensible pre-event price are genuinely valuable. Options granted at a post-event price often feel meaningless to the recipient because the obvious next step (the round, the deal) has already crystallised the value.

Multi-grant programmes

Companies that grant options regularly. Quarterly to new hires, annually as part of a refresh. Should adopt a rolling valuation cadence. The simplest pattern is to commission a fresh valuation every six to nine months, and to grant within the 90-day window of each agreed valuation. Outside those windows, grants either wait or trigger a refresh.

This rhythm becomes part of the company's people operations rather than a one-off corporate event. It also creates a clean audit trail for any future exit, where the buyer's diligence team will ask to see the valuation evidence behind every grant in the EMI register.

Notification to HMRC after grant

The valuation and the grant are only half the story. Each EMI grant must be notified to HMRC within a strict statutory deadline after the date of grant (currently 92 days). A missed notification means the grant is not an EMI grant at all. It is an unapproved option, taxed as employment income on exercise, with no CGT treatment of the spread.

Diary the notification on the day the option agreement is signed. The administration is straightforward. An online filing, but missed deadlines are unforgiving. We have seen otherwise clean schemes that were entirely lost because the notification slipped by a week.

What good timing looks like

The well-run EMI process looks like this: at the start of a quarter the board confirms the option pool and the recipients. The adviser is engaged immediately and a fresh valuation is in hand within four weeks. VAL231 goes to HMRC; agreement arrives two to four weeks later. Board minutes, option agreements and EMI notifications are prepared in parallel. Grants happen on a single day, with the agreement signed and dated by both parties, and the notification is filed inside the deadline. The whole cycle takes a couple of months and is repeatable for the next round of hires.

Owners who run it this way rarely have problems, at the company level, at the option-holder level, or in diligence at the eventual exit. Owners who improvise often inherit problems that surface only when the company is sold and the buyer's lawyers ask for evidence that does not exist.

What buyers' diligence teams look for years later

Every EMI grant a company makes today will eventually be reviewed by a buyer's tax and legal diligence team if the company is sold. They are looking for a clean, contemporaneous chain of evidence: the board minute approving the grant; the option agreement signed by both parties on a specific date; the valuation report and HMRC agreement that supported the price on that date; the EMI notification filed inside the statutory window; and the option register reconciling to the cap table.

Gaps in that chain are quantified as risk in the share-purchase agreement. Usually as a specific indemnity from the sellers covering any income-tax and NIC liability that arises if HMRC later challenges the grants. Indemnities are uncapped in time, capped in amount, and reduce the cash the sellers actually receive at completion. Companies that have run a tidy EMI process throughout their history close cleanly with no specific indemnity; companies that improvised typically face a holdback of 5–10% of consideration for two to seven years.

The cost of doing this properly at the time of each grant is trivial compared to the cost of fixing it under diligence pressure years later. Treat every grant as if a buyer's lawyer will read the file in five years, because they will.

Building an EMI calendar

Companies that grant options regularly benefit from formalising the cadence. A simple EMI calendar. Quarterly grant dates, with valuations refreshed every six to nine months. Turns an ad-hoc administrative burden into a predictable process. New hires are told at offer stage when their grant will land; the people team batches grants to a single date inside each valuation window; the finance and legal teams know when to expect the next refresh.

The calendar is also a planning tool. It surfaces the moments when a refresh is due and forces the conversation about whether anything material has changed. It aligns naturally with board meetings, year-end and funding-round timelines, and it gives the option-holders a clear expectation rather than a sequence of surprises. For companies granting more than four or five options a year, an EMI calendar pays for itself within two cycles, and it gives the auditors, future investors and any eventual buyer a clean, dated record of every grant decision the board has ever made.

Coordinating with founder, investor and customer milestones

EMI grants are rarely the only thing happening on the corporate calendar. Founder secondaries, investor follow-ons, customer contract renewals that re-rate the business, and statutory year-end all interact with the valuation. A grant scheduled the week before a priced funding round closes is almost always a missed opportunity. The lower pre-round valuation locks in cheaper options for the team, but only if the documentation actually completes on time.

The discipline is to map the next twelve months of corporate events onto the EMI calendar, identify the windows in which grants are most valuable for option holders and least disruptive for the company, and book the valuation work into those windows. Investors generally welcome the conversation: a properly run EMI process is a sign of corporate maturity, and the dilution it represents has already been modelled in their cap-table forecasts.

Where founders are themselves taking secondary liquidity in the same period, careful sequencing matters. The valuation evidence for the secondary should reconcile to the valuation evidence for the EMI grant, with any differences (typically driven by preference rights or restriction discounts on the ordinary shares) clearly explained. Inconsistent valuations across simultaneous transactions are a red flag in any later diligence.